News

Majesco to Showcase Innovative GenAI Solutions at JIF

Majesco to Showcase Innovative GenAI Solutions at JIF

Majesco: Leading the Charge at the Joint Industry Forum

Majesco, a renowned leader in cloud insurance solutions, is stepping into the limelight as a Platinum Sponsor at the upcoming Joint Industry Forum (JIF). This prestigious event promises to tackle pressing challenges in the insurance industry, focusing on climate resilience, legal system abuses, and the transformative impact of artificial intelligence (AI) and GenAI in risk management and operations.

Exciting Insights from Industry Experts

Majesco's participation is highlighted by two compelling speaking sessions hosted on the 20th of November. These sessions will feature insights from distinguished industry experts, including presenter's Patrick Davis and Denise Garth, who bring a wealth of knowledge and experience to the table.

AI and GenAI: Transforming Insurance

The first session, scheduled for 1:40 PM EST, will be led by Patrick Davis, the Senior Vice President and General Manager of Data & Analytics at Majesco. Patrick will delve into the significant potential of AI and GenAI in the insurance landscape. While many organizations may employ AI sporadically, Patrick will emphasize that a comprehensive strategy utilizing GenAI can profoundly change business operations. His session promises to enlighten insurers on deploying intelligent architectures and data strategies that foster competitive advantages and operational efficiencies.

Panel Discussion on Driving Innovation

Following Patrick's session, Denise Garth will lead a dynamic panel discussion from 1:55 PM to 2:50 PM EST. This panel will feature notable figures, including Jim Boccher, Peter Miller, Kenneth Tolson, and Reggie Townsend. Together, they will explore the latest innovations shaping risk management. The discussion will include how GenAI and predictive modeling are phenomena that enhance underwriting processes, reduce losses, and ultimately enrich the customer experience.

Engaging Opportunities for Attendees

Beyond these enlightening sessions, attendees will have the chance to engage with Majesco’s team at their dedicated table in the foyer. Here, visitors can explore Majesco's latest technological advancements in intelligent insurance solutions, setting the stage for informed conversations about their impact on the insurance sector.

About Majesco

Majesco has become the trusted partner for property and casualty (P&C) and life & annuity (L&A) insurers seeking to enhance customer experiences. The company combines technology with industry expertise to navigate the challenges of today, while also preparing clients for the future. With over 350 insurers—including startups, MGAs, and large reinsurers—using Majesco’s intelligent SaaS platforms, the company’s solutions are prominently recognized in data analytics, distribution, underwriting, and digital initiatives.

Majesco believes that effective risk management is about embracing change rather than avoiding it. With a track record of over 1000 successful implementations and a cloud adoption rate exceeding 90% among its clients, Majesco stands at the forefront of digital transformation in the insurance sector. This commitment gives organizations the confidence to make well-informed decisions, the tools to excel in performance, and the support required to ensure successful execution.

For more information, interested parties are encouraged to visit www.majesco.com and follow Majesco on LinkedIn.

Frequently Asked Questions

What is the Joint Industry Forum?

The Joint Industry Forum is an event that focuses on significant challenges and innovations in the insurance sector.

Who will be presenting at Majesco's sessions?

Patrick Davis and Denise Garth will lead the sessions, along with various distinguished panelists from the industry.

What topics will be discussed during the sessions?

Topics include the impact of AI and GenAI on the insurance sector, innovations in risk management, and strategies for enhancing underwriting and customer experience.

How can attendees engage with Majesco at the event?

Attendees can visit the Majesco table in the foyer area to learn more about the latest insurance technology solutions and engage with the team.

What is the business focus of Majesco?

Majesco provides cloud insurance solutions aimed at enhancing the customer experience while navigating industry challenges through intelligent technology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Exro Technologies Reveals Quarterly Progress and Financial Insights

Updated Category News Views 362

Exro Technologies Reports First Quarter Results Exro Technologies Inc. (TSX: EXRO), a prominent tech company specializing in power control solutions for electric vehicles and energy storage, has recently announced its financial results for the first quarter of the year. This highlights their ongoing transition from technology validation towards commercial operations and...

Continue Reading
dsm-firmenich Appoints New Leaders to Propel Future Growth

Updated Category News Views 548

dsm-firmenich Welcomes New Executive Committee Members dsm-firmenich is set to usher in a transformative era by strengthening its Executive Committee, as it embarks on a journey to intensify its consumer-centered approach. This restructuring aims to solidify its standing as a top-tier partner in creation and innovation across the nutrition, health, and beauty sectors. The...

Continue Reading
Insight Partners Rolls Out $12.5B for Software Innovation Growth

Updated Category News Views 805

Insight Partners Launches New Funds to Propel Software Innovation Global software investor, Insight Partners, has recently celebrated a significant milestone by announcing the closing of its thirteenth flagship fund alongside a dedicated buyout co-invest fund, collectively known as "Fund XIII". This announcement is particularly special as it coincides with the firm's 30th...

Continue Reading
Acumatica's AI Innovations Transform Business Operations

Updated Category News Views 123

Acumatica's AI Innovations Transform Business Operations During an inspiring keynote at a recent summit, Acumatica showcased its commitment to revolutionizing business operations with an AI-first product strategy. This innovative approach aims to significantly enhance how small and mid-sized businesses operate, addressing the real-world challenges they face. With advanced...

Continue Reading
Microbiological Testing of Water Market Growth Forecasts

Updated Category News Views 101

The Expanding Microbiological Testing of Water Market As the demand for clean and safe water continues to surge, the global microbiological testing of water market is set to experience significant growth, reaching an impressive $2.3 billion by 2027, with a robust compound annual growth rate (CAGR) of 7.4%. The rising consciousness among consumers regarding the importance...

Continue Reading